Philips NV

Equities

PHIA

NL0000009538

Advanced Medical Equipment & Technology

Market Closed - Euronext Amsterdam Other stock markets 16:55:00 06/02/2026 GMT			5-day change	1st Jan Change
24.79 ^EUR	+0.85%		+2.27%	+6.67%

02-04	PHILIPS NV : Buy rating from Barclays	ZD
02-03	Preciseonco research consortium awarded EUR 14.9 million grant in precision cancer treatment	RE

Royal Philips lifts outlook after Q3 profitability beat and stronger orders

Royal Philips delivered a solid Q3, with profitability beating expectations and order intake strengthening, particularly in North America. Management now expects margins at the upper end of its 2025 target range, underpinned by productivity gains and a robust Innovation pipeline.

Published on 11/04/2025 at 03:05 pm GMT - Modified on 11/04/2025 at 02:30 pm GMT

Alphavalue

This article is reserved for subscribers.

Alphavalue, the European leader in independent research, is exclusively available on MarketScreener.

To unlock the article, subscribe!

Latest news about Philips NV

02-04	PHILIPS NV : Buy rating from Barclays	ZD
02-03	Preciseonco research consortium awarded EUR 14.9 million grant in precision cancer treatment	RE
01-28	KBC Securities Kicks Off Royal Philips Coverage at Accumulate	MT
01-26	Earnings calendar for January 26 to 30, 2026: Microsoft, Apple, LVMH and ASML ahead
01-23	European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading; Up 1.4% for Week	MT
01-22	PHILIPS NV : UBS gives a Buy rating	ZD
01-20	Global drugmakers rush to boost US presence as tariff threat looms	RE
01-16	European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading; Rise 2% for Week	MT
01-16	PHILIPS NV : Jefferies gives a Neutral rating	ZD
01-15	PHILIPS NV : Gets a Buy rating from UBS	ZD
01-13	Emergency Care Holdings completed the acquisition of Emergency Care business of Koninklijke Philips N.V.	CI
01-13	Global drugmakers rush to boost US presence as tariff threat looms	RE
01-13	PHILIPS NV : Bernstein remains Neutral	ZD
01-12	PHILIPS NV : Barclays remains its Buy rating	ZD
12-31	European Equities Traded in the US as American Depositary Receipts Decline Wednesday	MT
12-30	Koninklijke Philips N.V.'d Equity Buyback announced on June 14, 2023, has expired.	CI
12-23	PHILIPS NV : Jefferies remains Neutral	ZD
12-18	RBC Starts Philips at Sector Perform, Says Valuation 'Justified'	MT
12-18	PHILIPS NV : JP Morgan remains Neutral	ZD
12-17	European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading	MT
12-17	Greek media group Antenna aims to 'internationalise' GEDI editorial assets, source says	RE
12-17	RBC Capital Begins Royal Philips Coverage at Sector Perform	MT
12-17	Bernstein Resumes Philips Coverage at Market Perform, Says FY26 Expectations 'Too High' Amid China, Tariff Risks	MT
12-17	PHILIPS NV : Barclays reaffirms its Buy rating	ZD
12-17	PHILIPS NV : From a Buy to Neutral rating by RBC	ZD

Chart Philips NV

Duration

Period

PHIA: Dynamic Chart

Company Profile

Koninklijke Philips N.V. is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. The group leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Koninklijke Philips N.V. is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care.

Employees

67,035

Sector

Advanced Medical Equipment & Technology

Calendar

02-09 - Capital Markets Day

More about the company